Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162299
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-03
First Post:
2023-11-22
Brief Title:
A Phase I The Study to Evaluate the Safety Immunogenicity and Efficacy of YS-HBV-002
Sponsor:
Yisheng Biopharma Singapore Pte Ltd
Organization:
Yisheng Biopharma Singapore Pte Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-22
First Submit QC Date:
November 30 2023
Study First Post Date:
2023-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-02
Last Update Post Date:
2024-04-03
Last Update Post Date Type:
ACTUAL